Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.

Lucanthone and hycanthone are thioxanthenone DNA intercalators used in the 1980s as antitumor agents. Lucanthone is in Phase I clinical trial, whereas hycanthone was pulled out of Phase II trials. Their potential mechanism of action includes DNA intercalation, inhibition of nucleic acid biosyntheses...

Full description

Saved in:
Bibliographic Details
Main Authors: Mamta D Naidu, Rakhi Agarwal, Louis A Pena, Luis Cunha, Mihaly Mezei, Min Shen, David M Wilson, Yuan Liu, Zina Sanchez, Pankaj Chaudhary, Samuel H Wilson, Michael J Waring
Format: Article
Language:English
Published: Public Library of Science (PLoS) 2011-01-01
Series:PLoS ONE
Online Access:https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023679&type=printable
Tags: Add Tag
No Tags, Be the first to tag this record!
_version_ 1849727529851551744
author Mamta D Naidu
Rakhi Agarwal
Louis A Pena
Luis Cunha
Mihaly Mezei
Min Shen
David M Wilson
Yuan Liu
Zina Sanchez
Pankaj Chaudhary
Samuel H Wilson
Michael J Waring
author_facet Mamta D Naidu
Rakhi Agarwal
Louis A Pena
Luis Cunha
Mihaly Mezei
Min Shen
David M Wilson
Yuan Liu
Zina Sanchez
Pankaj Chaudhary
Samuel H Wilson
Michael J Waring
author_sort Mamta D Naidu
collection DOAJ
description Lucanthone and hycanthone are thioxanthenone DNA intercalators used in the 1980s as antitumor agents. Lucanthone is in Phase I clinical trial, whereas hycanthone was pulled out of Phase II trials. Their potential mechanism of action includes DNA intercalation, inhibition of nucleic acid biosyntheses, and inhibition of enzymes like topoisomerases and the dual function base excision repair enzyme apurinic endonuclease 1 (APE1). Lucanthone inhibits the endonuclease activity of APE1, without affecting its redox activity. Our goal was to decipher the precise mechanism of APE1 inhibition as a prerequisite towards development of improved therapeutics that can counteract higher APE1 activity often seen in tumors. The IC(50) values for inhibition of APE1 incision of depurinated plasmid DNA by lucanthone and hycanthone were 5 µM and 80 nM, respectively. The K(D) values (affinity constants) for APE1, as determined by BIACORE binding studies, were 89 nM for lucanthone/10 nM for hycanthone. APE1 structures reveal a hydrophobic pocket where hydrophobic small molecules like thioxanthenones can bind, and our modeling studies confirmed such docking. Circular dichroism spectra uncovered change in the helical structure of APE1 in the presence of lucanthone/hycanthone, and notably, this effect was decreased (Phe266Ala or Phe266Cys or Trp280Leu) or abolished (Phe266Ala/Trp280Ala) when hydrophobic site mutants were employed. Reduced inhibition by lucanthone of the diminished endonuclease activity of hydrophobic mutant proteins (as compared to wild type APE1) supports that binding of lucanthone to the hydrophobic pocket dictates APE1 inhibition. The DNA binding capacity of APE1 was marginally inhibited by lucanthone, and not at all by hycanthone, supporting our hypothesis that thioxanthenones inhibit APE1, predominantly, by direct interaction. Finally, lucanthone-induced degradation was drastically reduced in the presence of short and long lived free radical scavengers, e.g., TRIS and DMSO, suggesting that the mechanism of APE1 breakdown may involve free radical-induced peptide bond cleavage.
format Article
id doaj-art-8d44bed6eda94a51a3989f04a3a89c3e
institution DOAJ
issn 1932-6203
language English
publishDate 2011-01-01
publisher Public Library of Science (PLoS)
record_format Article
series PLoS ONE
spelling doaj-art-8d44bed6eda94a51a3989f04a3a89c3e2025-08-20T03:09:48ZengPublic Library of Science (PLoS)PLoS ONE1932-62032011-01-0169e2367910.1371/journal.pone.0023679Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.Mamta D NaiduRakhi AgarwalLouis A PenaLuis CunhaMihaly MezeiMin ShenDavid M WilsonYuan LiuZina SanchezPankaj ChaudharySamuel H WilsonMichael J WaringLucanthone and hycanthone are thioxanthenone DNA intercalators used in the 1980s as antitumor agents. Lucanthone is in Phase I clinical trial, whereas hycanthone was pulled out of Phase II trials. Their potential mechanism of action includes DNA intercalation, inhibition of nucleic acid biosyntheses, and inhibition of enzymes like topoisomerases and the dual function base excision repair enzyme apurinic endonuclease 1 (APE1). Lucanthone inhibits the endonuclease activity of APE1, without affecting its redox activity. Our goal was to decipher the precise mechanism of APE1 inhibition as a prerequisite towards development of improved therapeutics that can counteract higher APE1 activity often seen in tumors. The IC(50) values for inhibition of APE1 incision of depurinated plasmid DNA by lucanthone and hycanthone were 5 µM and 80 nM, respectively. The K(D) values (affinity constants) for APE1, as determined by BIACORE binding studies, were 89 nM for lucanthone/10 nM for hycanthone. APE1 structures reveal a hydrophobic pocket where hydrophobic small molecules like thioxanthenones can bind, and our modeling studies confirmed such docking. Circular dichroism spectra uncovered change in the helical structure of APE1 in the presence of lucanthone/hycanthone, and notably, this effect was decreased (Phe266Ala or Phe266Cys or Trp280Leu) or abolished (Phe266Ala/Trp280Ala) when hydrophobic site mutants were employed. Reduced inhibition by lucanthone of the diminished endonuclease activity of hydrophobic mutant proteins (as compared to wild type APE1) supports that binding of lucanthone to the hydrophobic pocket dictates APE1 inhibition. The DNA binding capacity of APE1 was marginally inhibited by lucanthone, and not at all by hycanthone, supporting our hypothesis that thioxanthenones inhibit APE1, predominantly, by direct interaction. Finally, lucanthone-induced degradation was drastically reduced in the presence of short and long lived free radical scavengers, e.g., TRIS and DMSO, suggesting that the mechanism of APE1 breakdown may involve free radical-induced peptide bond cleavage.https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023679&type=printable
spellingShingle Mamta D Naidu
Rakhi Agarwal
Louis A Pena
Luis Cunha
Mihaly Mezei
Min Shen
David M Wilson
Yuan Liu
Zina Sanchez
Pankaj Chaudhary
Samuel H Wilson
Michael J Waring
Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
PLoS ONE
title Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
title_full Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
title_fullStr Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
title_full_unstemmed Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
title_short Lucanthone and its derivative hycanthone inhibit apurinic endonuclease-1 (APE1) by direct protein binding.
title_sort lucanthone and its derivative hycanthone inhibit apurinic endonuclease 1 ape1 by direct protein binding
url https://journals.plos.org/plosone/article/file?id=10.1371/journal.pone.0023679&type=printable
work_keys_str_mv AT mamtadnaidu lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT rakhiagarwal lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT louisapena lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT luiscunha lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT mihalymezei lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT minshen lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT davidmwilson lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT yuanliu lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT zinasanchez lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT pankajchaudhary lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT samuelhwilson lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding
AT michaeljwaring lucanthoneanditsderivativehycanthoneinhibitapurinicendonuclease1ape1bydirectproteinbinding